Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Woodcock, Marks Recusals From COVID-19 Product Reviews 'Protect FDA's Reputation'
May 20 2020
•
By
Brenda Sandburg
Top FDA officials recuse themsleves from COVID-19 product review decisions
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from US FDA
More from Agency Leadership